Pitofsky Jason

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pitofsky Jason's trades of Regeneron Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-06 2026-11-04
S Sale
19,887 +36.7%
221.92
US$1,898,480 		19,887 +36.7% 221.92 US$1,898,480
2026-11-06 2026-11-04
S Sale
83,427 -19.4%
113.43
US$45,582 		83,427 -19.4% 113.43 US$45,582
2026-11-06 2026-11-04
S Sale
10,866 -43.1%
449.16
US$779,024 		10,866 -43.1% 449.16 US$779,024
2026-11-06 2026-11-04
S Sale
529 -10.7%
943.53
US$499,127 		529 -10.7% 943.53 US$499,127
2026-11-06 2026-11-04
S Sale
1,215 -19.7%
942.31
US$1,144,907 		1,215 -19.7% 942.31 US$1,144,907
2026-11-06 2026-11-04
S Sale
982 -13.8%
941.58
US$924,632 		982 -13.8% 941.58 US$924,632
2026-11-06 2026-11-04
S Sale
575 -7.5%
940.46
US$540,764 		575 -7.5% 940.46 US$540,764
2026-11-06 2026-11-04
S Sale
439 -5.4%
939.57
US$412,471 		439 -5.4% 939.57 US$412,471
2026-11-04 2026-11-04
PrS Proposed sale
180
973.36
US$175,205 		180 973.36 US$175,205
2026-11-04 2026-11-04
PrS Proposed sale
3,883
976.00
US$3,789,808 		3,883 976.00 US$3,789,808
2026-02-11 2026-02-09
PlS Planned sale
53 -1.2%
785.72
US$41,643 		53 -1.2% 785.72 US$41,643
2026-02-11 2026-02-09
PlS Planned sale
1 -0.0%
784.66
US$785 		1 -0.0% 784.66 US$785
2026-02-11 2026-02-09
PlS Planned sale
144 -3.2%
783.23
US$112,785 		144 -3.2% 783.23 US$112,785
2026-02-11 2026-02-09
PlS Planned sale
37 -0.8%
782.67
US$28,959 		37 -0.8% 782.67 US$28,959
2026-02-11 2026-02-09
PlS Planned sale
26 -0.6%
781.37
US$20,316 		26 -0.6% 781.37 US$20,316
2026-02-11 2026-02-09
PlS Planned sale
75 -1.6%
780.06
US$58,504 		75 -1.6% 780.06 US$58,504
2026-02-11 2026-02-09
PlS Planned sale
205 -4.3%
779.56
US$159,810 		205 -4.3% 779.56 US$159,810
2026-02-11 2026-02-09
PlS Planned sale
563 -10.5%
778.35
US$438,211 		563 -10.5% 778.35 US$438,211
2026-02-11 2026-02-09
PlS Planned sale
391 -6.8%
777.51
US$304,006 		391 -6.8% 777.51 US$304,006
2026-02-11 2026-02-09
PlS Planned sale
521 -8.3%
776.43
US$404,520 		521 -8.3% 776.43 US$404,520
2026-02-11 2026-02-09
PlS Planned sale
20 -0.3%
775.95
US$15,519 		20 -0.3% 775.95 US$15,519
2026-02-09 2026-02-09
PrS Proposed sale
2,036
783.17
US$1,594,534 		2,036 783.17 US$1,594,534
2025-11-10 2025-11-07
S Sale
431 -9.2%
651.43
US$280,766 		431 -9.2% 651.43 US$280,766
2025-11-07 2025-11-07
PrS Proposed sale
431
651.00
US$280,581 		431 651.00 US$280,581
2024-08-07 2024-08-07
PrS Proposed sale
487
1,069.75
US$520,970 		487 1,069.75 US$520,970
2024-08-07 2024-08-07
S Sale
487 -10.4%
1,070.00
US$521,090 		487 -10.4% 1,070.00 US$521,090